期刊文献+

2007—2009年解放军总医院口服治疗良性前列腺增生症药物使用情况分析

Use of Oral Drugs against Benign Prostatic Hyperplasia in General Hospital of Chinese PLA During 2007-2009 Period
下载PDF
导出
摘要 目的:了解我院口服治疗良性前列腺增生症(BPH)药物应用现状和趋势。方法:收集我院2007—2009年用药数据库内的口服治疗BPH药物消耗数据,用Excel对药物品种、用药金额、用药频度(DDDs)等进行统计和分析。结果:我院口服治疗BPH药物的用量呈逐年上升趋势。其中肾上腺素能α1a受体阻断剂坦索罗辛在我院应用广泛。结论:我院口服治疗BPH药物应用总体合理,用量逐年增加。选择安全、有效、依从性好的药物是治疗BPH的必然发展趋势。 OBJECTIVE: To probe into the utilization of oral drugs against benign prostatic hyperplasia(BPH) and its tendency.METHODS: The drug consumption data of the oral anti-BPH drugs during 2007-2009 period were retrieved from database for statistical analysis regarding drug varieties,consumption sum and DDDs using Excel.RESULTS: The consumption quantity of oral anti-BPH drugs was increasing year by year.Tamsulosin,as a representative of the α1a adrenaline receptor antagonist,has been widely used in our hospital.CONCLUSION: In general,the use of oral anti-BPH in our hospital was rational,and the consumption quantity of which was increasing year on year.Safe,effective anti-BPH therapy with good compliance surely enjoys promising future.
出处 《中国医院用药评价与分析》 2011年第9期780-782,共3页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 治疗良性前列腺增生症药物 用药分析 用药频度 坦索罗辛 Drugs for benign prostatic hyperplasia Drug use analysis DDDs Tamsulosin
  • 相关文献

参考文献8

二级参考文献53

共引文献101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部